--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company ... $20 million in Series A extension funding committed by Apple Tree Partners (ATP). The funds will be used to advance Aulos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback